亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Prostate Radiotherapy in Low-volume Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysis

医学 多西紫杉醇 前列腺癌 荟萃分析 肿瘤科 雄激素剥夺疗法 内科学 随机对照试验 恩扎鲁胺 癌症 雄激素受体
作者
Soumyajit Roy,Gagan Fervaha,Daniel E. Spratt,Yilun Sun,Amar U. Kishan,Andrew Loblaw,Shawn Malone,Michael Ong,Fred Saad,Christopher J.D. Wallis,Scott C. Morgan
出处
期刊:European Urology [Elsevier BV]
卷期号:86 (1): 10-17 被引量:8
标识
DOI:10.1016/j.eururo.2024.03.018
摘要

The utility of prostate radiotherapy (RT) is unclear in men with metastatic hormone-sensitive prostate cancer (mHSPC) receiving intensified systemic therapy with androgen deprivation therapy (ADT) and androgen receptor pathway inhibitors (ARPIs). We performed a network meta-analysis of randomized controlled trials (RCTs) to investigate the role of prostate RT in low-volume mHSPC. Bibliographic databases and conference proceedings were searched through July 2023 for RCTs evaluating the addition of ARPIs or prostate RT to standard of care (SOC) systemic therapy, defined as ADT or ADT plus docetaxel, for the initial treatment of mHSPC. We focused exclusively on aggregate data from the low-volume mHSPC subpopulation in these trials. We pooled the treatment arms into four groups: SOC, SOC plus ARPI, SOC plus RT, and SOC plus ARPI plus RT. The primary outcome was overall survival (OS). To compare treatment strategies, a fixed-effects Bayesian network meta-analysis was undertaken, while a Bayesian network meta-regression was performed to account for across-trial differences in docetaxel use as part of SOC and in proportions of patients with de novo presentation. Ten RCTs comprising 4423 patients were eligible. The Surface Under the Cumulative Ranking Curve scores were 0.0006, 0.45, 0.62, and 0.94 for SOC, SOC plus RT, SOC plus ARPI, and SOC plus ARPI plus RT, respectively. On a meta-regression, in a population with de novo mHSPC and no docetaxel use, we did not find sufficient evidence of a difference in OS between SOC plus ARPI plus RT versus SOC plus ARPI (hazard ratio [HR]: 0.76; 95% credible interval: 0.51–1.16) and SOC plus RT versus SOC plus ARPI (HR: 1.10; 95% credible interval: 0.92–1.42). There was some evidence that SOC plus ARPI plus RT reduced mortality compared with the next best strategy of SOC plus ARPI in patients with low-volume de novo mHSPC. A meta-analysis with individual patient data or an RCT is needed to confirm these findings.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
liudy发布了新的文献求助10
4秒前
领导范儿应助科研通管家采纳,获得10
10秒前
34秒前
阿紫吖完成签到 ,获得积分10
36秒前
过时的白曼完成签到,获得积分10
37秒前
隐形曼青应助三叔采纳,获得10
51秒前
1分钟前
陈苗发布了新的文献求助10
1分钟前
在水一方应助scholar丨崔采纳,获得10
1分钟前
不能随便完成签到,获得积分10
1分钟前
2分钟前
碧蓝香芦完成签到 ,获得积分10
2分钟前
scholar丨崔发布了新的文献求助10
2分钟前
2分钟前
2分钟前
可爱的函函应助陈苗采纳,获得10
2分钟前
北北完成签到 ,获得积分10
2分钟前
2分钟前
2分钟前
Nowind发布了新的文献求助10
2分钟前
三叔发布了新的文献求助10
2分钟前
三叔完成签到,获得积分0
2分钟前
怕孤单的绿柏完成签到,获得积分10
2分钟前
Augustines完成签到,获得积分10
3分钟前
3分钟前
lijunliang完成签到 ,获得积分10
3分钟前
Lucas应助欣喜的以丹采纳,获得10
3分钟前
爱吃煎饼果子的芋圆完成签到 ,获得积分10
3分钟前
3分钟前
小神仙完成签到 ,获得积分10
3分钟前
尊敬夜南发布了新的文献求助10
3分钟前
sss发布了新的文献求助10
3分钟前
123发布了新的文献求助10
3分钟前
科研通AI5应助sss采纳,获得10
3分钟前
4分钟前
章水云发布了新的文献求助10
4分钟前
psyche完成签到,获得积分10
4分钟前
fighting完成签到,获得积分10
4分钟前
小马甲应助sljzhangbiao11采纳,获得10
4分钟前
大模型应助最溜皮大爷采纳,获得10
5分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990022
求助须知:如何正确求助?哪些是违规求助? 3532092
关于积分的说明 11256327
捐赠科研通 3270943
什么是DOI,文献DOI怎么找? 1805140
邀请新用户注册赠送积分活动 882270
科研通“疑难数据库(出版商)”最低求助积分说明 809228